Safety, Tolerability, and Pharmacokinetics of Multiple Doses of Oral EC5026 in Healthy Subjects
Clinical trial NCT06089837 · COMPLETED
Trial details
- NCT number
- NCT06089837
- Sponsor
- EicOsis Human Health Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-28
- Primary completion
- 2024-03-13
- Enrollment
- 16
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.